ARCA Biopharma Inc ABIO:NASDAQ

RT Quote | NASDAQ | USD
Last | 4:00 PM EDT
2.29quote price arrow down-0.02 (-0.87%)
Volume
93,402
52 week range
1.71 - 3.90
Loading...
  • Open2.26
  • Day High2.36
  • Day Low2.26
  • Prev Close2.31
  • 52 Week High3.90
  • 52 Week High Date06/14/21
  • 52 Week Low1.71
  • 52 Week Low Date01/24/22

Key Stats

  • Market Cap33.00M
  • Shares Out14.41M
  • 10 Day Average Volume0.10M
  • Dividend-
  • Dividend Yield-
  • Beta2.18
  • YTD % Change6.51

KEY STATS

  • Open2.26
  • Day High2.36
  • Day Low2.26
  • Prev Close2.31
  • 52 Week High3.90
  • 52 Week High Date06/14/21
  • 52 Week Low1.71
  • 52 Week Low Date01/24/22
  • Market Cap33.00M
  • Shares Out14.41M
  • 10 Day Average Volume0.10M
  • Dividend-
  • Dividend Yield-
  • Beta2.18
  • YTD % Change6.51

RATIOS/PROFITABILITY

  • EPS (TTM)-1.28
  • P/E (TTM)-1.78
  • Fwd P/E (NTM)-0.26
  • EBITDA (TTM)-18.492M
  • ROE (TTM)-32.49%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On ARCA Biopharma Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
ARCA biopharma, Inc. (ARCA) is a biopharmaceutical company, which is focused on development and commercialization of targeted therapies for cardiovascular diseases. The Company's lead product includes Recombinant Nematode Anticoagulant Protein c2, or rNAPc2 (AB201) and Gencaro (bucindolol hydrochloride). rNAPc2 (AB201) is a treatment for diseases caused by ribonucleic acid (RNA), viruses, focusing on COVID-19, the disease syndrome caused by the SARS-CoV-2 virus. The gencaro...
Robert Conway CPA
Independent Chairman of the Board
Michael Bristow M.D., Ph.D.
President, Chief Executive Officer, Director
Thomas Keuer
Chief Operating Officer
C. Jeffrey Dekker CPA
Chief Financial Officer, Principal Accounting Officer
Christopher Graybill Ph.D.
Vice President, Clinical Development
Address
10170 Church Ranch Way, Suite 100
Westminster, CO
80021
United States

Top Peers

SYMBOLLASTCHG%CHG
TARA
Protara Therapeutics Inc
3.12+0.23+7.96%
ASLN
Aslan Pharmaceuticals Ltd
0.463-0.002-0.4301%
SPRB
Spruce Biosciences Inc
1.34-0.02-1.47%
TCON
TRACON Pharmaceuticals Inc
1.93+0.26+15.57%
RGLS
Regulus Therapeutics Inc
0.189-0.0263-12.2155%
ALRN
Aileron Therapeutics Inc
0.3755-0.0121-3.1218%